The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2005
Filed:
Jun. 11, 2003
Mark B. Anderson, Orinda, CA (US);
Lance Christopher Christie, Ballwin, CA (US);
Quyen-quyen Thuy DO, San Diego, CA (US);
Jun Feng, Carlsbad, CA (US);
Yufeng Hong, San Diego, CA (US);
Haitao LI, San Diego, CA (US);
Ved P. Pathak, San Diego, CA (US);
Ranjan Jagath Rajapakse, San Diego, CA (US);
Eric T. Sun, San Diego, CA (US);
Eileen Valenzuela Tompkins, Escondido, CA (US);
Mark B. Anderson, Orinda, CA (US);
Lance Christopher Christie, Ballwin, CA (US);
Quyen-Quyen Thuy Do, San Diego, CA (US);
Jun Feng, Carlsbad, CA (US);
Yufeng Hong, San Diego, CA (US);
Haitao Li, San Diego, CA (US);
Ved P. Pathak, San Diego, CA (US);
Ranjan Jagath Rajapakse, San Diego, CA (US);
Eric T. Sun, San Diego, CA (US);
Eileen Valenzuela Tompkins, Escondido, CA (US);
Agouron Pharmaceuticals, Inc., San Diego, CA (US);
Pfizer Inc., New York, NY (US);
Abstract
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.